JafarKafaieMDPhD

Neurology • Saint Louis, MO

Neuromuscular Medicine

Director, neurology residency program

Join to view full profile

Dr. Kafaie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kafaie's full profile

Already have an account?

Office
1008 S. Spring
SLUCare Academic Pavilion
Saint Louis, MO 63110
Phone+1 314-977-6082

Fax+1 314-977-6086

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Neuromuscular Medicine (Neurology), 2012 - 2013
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2009 - 2012
Hurley Medical Center/Michigan State UniversityInternship, Internal Medicine, 2008 - 2009
Tehran University of Medical Sciences School of MedicineClass of 1994

Certifications & Licensure

IL State Medical License 2015 - 2026
MO State Medical License 2012 - 2025
CA State Medical License 2013 - 2022
MI State Medical License 2008 - 2009
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Clinical Trials

Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Start of enrollment: 2015 Dec 01
Completed
Phase 3
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases Start of enrollment: 2015 Dec 01
Completed
A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) Start of enrollment: 2018 Dec 21
Completed
Phase 3

Publications & Presentations

PubMed

47 citations
HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the dis of stem : Loop 1 initiates viral RNA dimerization
Rujun Song, Jafar Kafaie, Long Yang, Michael Laughrea
Journal of Molecular Biology. 2007-08-24
24 citations
A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A
Shahram Attarian, Peter Young, Thomas H. Brannagan, David H. Adams, Philip Van Damme
Orphanet Journal of Rare Diseases. 2021-10-16
2 citations
Longitudinal 16-year study of dominant intermediate CMT type C neuropathy.
Yi Pan, Jafar Kafaie, Florian P. Thomas
Muscle & Nerve. 2020-01-01

Journal Articles

Effects of noninvasive ventilation in amyotrophic lateral sclerosis: The complication of bulbar impairment
Junghyun Kim, John Daniel Bireley, Ghazala Hayat, and Jafar Kafaie, Clinical & Translational Neuroscience, 3/31/2020